Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio Net Income (Quarterly) : 43.66M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.66M |
| March 31, 2026 | -8.278M |
| December 31, 2025 | -5.852M |
| September 30, 2025 | 16.02M |
| June 30, 2025 | -9.703M |
| March 31, 2025 | -9.439M |
| December 31, 2024 | -11.04M |
| September 30, 2024 | -11.47M |
| June 30, 2024 | -16.24M |
| March 31, 2024 | -19.03M |
| December 31, 2023 | -20.24M |
| September 30, 2023 | -18.37M |
| June 30, 2023 | -18.63M |
| Date | Value |
|---|---|
| March 31, 2023 | -17.32M |
| December 31, 2022 | -16.20M |
| September 30, 2022 | -18.37M |
| June 30, 2022 | -17.58M |
| March 31, 2022 | -14.50M |
| December 31, 2021 | -12.42M |
| September 30, 2021 | -10.20M |
| June 30, 2021 | -11.13M |
| March 31, 2021 | -13.28M |
| December 31, 2020 | -10.52M |
| September 30, 2020 | -7.155M |
| June 30, 2020 | -4.893M |
| March 31, 2020 | -3.881M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Q32 Bio, Inc. | -8.946M |
| Beam Therapeutics, Inc. | -122.68M |
| C4 Therapeutics, Inc. | -23.64M |
| Cullinan Therapeutics, Inc. | -53.70M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -43.66M |
| EPS Diluted (Quarterly) | 7.531 |
| Enterprise Value | -3.534M |
| Earnings Yield | 46.50% |
| Normalized Earnings Yield | 14.75 |